UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in metabolic syndrome associated with prostate change over a 5 year period: Multicenter study

European urology open science (Online), 2020-07, Vol.19, p.e1149-e1150

2020

Volltextzugriff (PDF)

Immunotherapy with dendritic cells derived from bone marrow hematopoietic stems cells inhibited tumor growth on a TRAMP-C1 syngeneic mouse model of prostate cancer

European urology open science (Online), 2020-07, Vol.19, p.e1834-e1835

2020

Volltextzugriff (PDF)

The renal tumor contact surface area using deep convolutional neural net is new method for predicting the renal function after partial nephrectomy

European urology open science (Online), 2020-07, Vol.19, p.e1933-e1934

2020

Volltextzugriff (PDF)

Fully automated evaluation of contact surface area between renal cell carcinoma and kidney parenchyma using deep convolutional neural net

European urology open science (Online), 2020-07, Vol.19, p.e2011-e2012

2020

Volltextzugriff (PDF)

Clinical outcomes and optimal strategies in primary female urethral cancer - a retrospective analysis at a single institute

European urology open science (Online), 2020-07, Vol.19, p.e561

2020

Volltextzugriff (PDF)

Early experiences of ureterectomy and ileal ureter replacement for urothelial carcinoma of ureter

European urology open science (Online), 2020-07, Vol.19, p.e1696-e1697

2020

Volltextzugriff (PDF)

UP-02.100 Antitumor Effect of Sodium Metaarsenite on the Prostate Cancer Cell and Its Mechanism

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S294-S294

2011

Volltextzugriff (PDF)

Prognostic factor and cancer-specific survival of the surgically managed renal cell carcinoma with venous thrombus: Thirty-year experience of single tertiary medical center

European urology, 2024-03, Vol.85, p.S2158

2024

Volltextzugriff (PDF)

A1044 - Prognostic factor and cancer-specific survival of the surgically managed renal cell carcinoma with venous thrombus: Thirty-year experience of single tertiary medical center

European urology, 2024-03, Vol.85, p.S2158-S2158

2024

Volltextzugriff (PDF)

Artificial intelligence based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: Development and multi-center validation

European urology, 2024-03, Vol.85, p.S861

2024

Volltextzugriff (PDF)

A0135 - Artificial intelligence based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: Development and multi-center validation

European urology, 2024-03, Vol.85, p.S861-S861

2024

Volltextzugriff (PDF)

Development and validation of the artificial intelligence-based disease-free status prediction model for upper-urinary tract urothelial carcinoma patient with radical nephroureterectomy

European urology, 2023-02, Vol.83, p.S1323

2023

Volltextzugriff (PDF)

A0927 - Development and validation of the artificial intelligence-based disease-free status prediction model for upper-urinary tract urothelial carcinoma patient with radical nephroureterectomy

European urology, 2023-02, Vol.83, p.S1323-S1323

2023

Volltextzugriff (PDF)

1817P A phase I/II efficacy and safety study of LAE001/prednisone and afuresertib in patients with metastatic castration-resistant prostate cancer (mCRPC) following 1-3 lines of standard of care

Annals of oncology, 2023-10, Vol.34, p.S985-S985

2023

Volltextzugriff (PDF)

MP-16.09: Preoperative Clinical and Pathological Characteristics of Pt0 Prostate Cancer in Radical Prostatectomy

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S122-S122

2009

Volltextzugriff (PDF)

A0807 - A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia

European urology, 2024-03, Vol.85, p.S1807-S1808

2024

Volltextzugriff (PDF)

A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia

European urology, 2024-03, Vol.85, p.S1807-S1808

2024

Volltextzugriff (PDF)

MP-04.05: Development and DNA microarray analysis of cisplatin, gemcitabine and docetaxel-resistant bladder cancer cell lines

Urology (Ridgewood, N.J.), 2007, Vol.70 (3), p.59-59

2007

Volltextzugriff (PDF)

What association exists between hypertension and simple renal cyst in a screened population?

Journal of human hypertension, 2013-09, Vol.27 (9), p.539-544

2013

Volltextzugriff (PDF)

336 Renal arterial infusion of adipose tissue-derived stromal vascular fraction protects the renal function against acute kidney injury induced by ischemia-reperfusion injury

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e336-e336

2016

Volltextzugriff (PDF)

P081 Efficacy of metronomic chemotherapy in metastatic castration resistant prostate cancer

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (5), p.139-139

2014

Volltextzugriff (PDF)

Analysis of errors in 3D printing phantoms for partial nephrectomy

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e1922-e1924

2017

Volltextzugriff (PDF)

851 Clinocopathological features of patients progressed into castration-resistant prostate cancer after radical prostatectomy

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e851-e851

2016

Volltextzugriff (PDF)

744 Indolent clinical outcomes of carcinoma in situ-associated pTa bladder tumour after bacillus Calmette-Guérine: Need for a new classification of carcinoma in situ

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e744-e744

2016

Volltextzugriff (PDF)

207 3rd course of BCG instillation to the patients with primary CIS of bladder: Is it safe?

European urology supplements : official journal of the European Association of Urology, 2016-03, Vol.15 (3), p.e207-e207

2016

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(102)
Tagungsberichte
(1)

Sprache

Englisch
(101)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Changes in metabolic syndrome associated with prostate change over a 5 year period: Multicenter study

Immunotherapy with dendritic cells derived from bone marrow hematopoietic stems cells inhibited tumor growth on a TRAMP-C1 syngeneic mouse model of prostate cancer

The renal tumor contact surface area using deep convolutional neural net is new method for predicting the renal function after partial nephrectomy

Fully automated evaluation of contact surface area between renal cell carcinoma and kidney parenchyma using deep convolutional neural net

Clinical outcomes and optimal strategies in primary female urethral cancer - a retrospective analysis at a single institute

Early experiences of ureterectomy and ileal ureter replacement for urothelial carcinoma of ureter

UP-02.100 Antitumor Effect of Sodium Metaarsenite on the Prostate Cancer Cell and Its Mechanism

Prognostic factor and cancer-specific survival of the surgically managed renal cell carcinoma with venous thrombus: Thirty-year experience of single tertiary medical center

A1044 - Prognostic factor and cancer-specific survival of the surgically managed renal cell carcinoma with venous thrombus: Thirty-year experience of single tertiary medical center

Artificial intelligence based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: Development and multi-center validation

A0135 - Artificial intelligence based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: Development and multi-center validation

Development and validation of the artificial intelligence-based disease-free status prediction model for upper-urinary tract urothelial carcinoma patient with radical nephroureterectomy

A0927 - Development and validation of the artificial intelligence-based disease-free status prediction model for upper-urinary tract urothelial carcinoma patient with radical nephroureterectomy

1817P A phase I/II efficacy and safety study of LAE001/prednisone and afuresertib in patients with metastatic castration-resistant prostate cancer (mCRPC) following 1-3 lines of standard of care

MP-16.09: Preoperative Clinical and Pathological Characteristics of Pt0 Prostate Cancer in Radical Prostatectomy

A0807 - A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia

A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia

MP-04.05: Development and DNA microarray analysis of cisplatin, gemcitabine and docetaxel-resistant bladder cancer cell lines

What association exists between hypertension and simple renal cyst in a screened population?

336 Renal arterial infusion of adipose tissue-derived stromal vascular fraction protects the renal function against acute kidney injury induced by ischemia-reperfusion injury

P081 Efficacy of metronomic chemotherapy in metastatic castration resistant prostate cancer

Analysis of errors in 3D printing phantoms for partial nephrectomy

851 Clinocopathological features of patients progressed into castration-resistant prostate cancer after radical prostatectomy

744 Indolent clinical outcomes of carcinoma in situ-associated pTa bladder tumour after bacillus Calmette-Guérine: Need for a new classification of carcinoma in situ

207 3rd course of BCG instillation to the patients with primary CIS of bladder: Is it safe?

Suchergebnisse filtern